MFG
RARE icon

Merit Financial Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Merit Financial Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Buy
+13,993
New +$348K ﹤0.01% 1538

Other funds holding RARE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return

Merit Financial Group's RARE Position: Q2 2026 in Review

Merit Financial Group opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 13,993 shares worth $467K. The stake represents ﹤0.01% of the portfolio and ranks #1538 among its holdings.

21 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Merit Financial Group held 13,993 shares of Ultragenyx Pharmaceutical worth $467K as of Q2 2026.
  • Ultragenyx Pharmaceutical was a new Merit Financial Group position in Q2 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1538 holding.
  • 21 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.